MPM BioImpact Appoints Michael Ehlers, M.D., Ph.D., Experienced R&D Leader and Accomplished Biotechnology Executive, as Entrepreneur Partner [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
deliver transformative therapies to patients, today announced that Michael Ehlers, M.D., Ph.D., will join the Company as Entrepreneur Partner. "We are excited to welcome Mike, an esteemed biotechnology executive and research and development leader, to MPM BioImpact," said Ansbert Gadicke, M.D., Managing Partner of MPM BioImpact. "Our Entrepreneur Partners include global experts in the most innovative areas of biotechnology, with capabilities across the entire drug development process. They inform our investment decisions and provide meaningful, hands-on support to our portfolio companies. With his extensive experience as an accomplished scientist, drug developer, company creator and venture capitalist, Mike is an ideal addition to our Entrepreneur Partner team. We look forward to his many contributions as we continue to build and fund companies advancing leading technologies and driving breakthroughs to revolutionize patient care." MPM BioImpact Entrepreneur Partners serve as inve
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary [CNN]CNN
- Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary [CNN]CNN
- Vivo, OmniScience's genAI-powered clinical trial control tower, wins 2024 The Whale Tank competition at Innovation Network GatheringPR Web
- Pneumonia Vaccine Market Poised for Significant Expansion: Projected to Achieve $28 Billion by 2031 with a Robust 7.2% CAGR - Market Research Intellect [Yahoo! Finance]Yahoo! Finance
- PEGylated Proteins Market Set to Reach USD 19.1 Billion by 2031, Driven by Advancements in Drug Delivery: - Market Research Intellect [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 10/29/24 - Beat
PFE
Sec Filings
- 11/4/24 - Form 10-Q
- 11/1/24 - Form 4
- 11/1/24 - Form 4
- PFE's page on the SEC website